Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-13-034490
Filing Date
2013-06-12
Accepted
2013-06-12 14:40:20
Documents
2
Period of Report
2013-06-12

Document Format Files

Seq Description Document Type Size
1 6-K v347626_6k.htm 6-K 21884
2 GRAPHIC image_001.gif GRAPHIC 3133
  Complete submission text file 0001144204-13-034490.txt   27358
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 13908625
SIC: 2834 Pharmaceutical Preparations